Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Investigational Drug Shows Promise in Myotonic Dystrophy Type 1

(MedPage Today) -- Investigational zeleciment basivarsen (z-basivarsen) led to functional improvement in patients with myotonic dystrophy type 1 (DM1), data from the phase I/II ACHIEVE trial suggested. The analysis evaluated whether a larger group...

Investigational Drug Shows Promise in Myotonic Dystrophy Type 1

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Saturday 3 October →